Fueled by sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030, Evaluate projects.

AstraZeneca’s strong oncology performance was driven by medicines such as Tagrisso, Lynparza, Imfinzi, Calquence and Enhertu (in partnership with Daiichi Sankyo).

AstraZeneca is jointly developing and commercializing ENHERTU, which is the drug being evaluated in the DESTINY-Endometrial01 phase 3 trial, with Daiichi Sankyo under a global collaboration.

In the DESTINY-Breast09 trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, first-line trastuzumab deruxtecan (T-DXd; Enhertu) combined with pertuzumab ...

NEW YORK – The US Food and Drug Administration on Thursday approved Merck's PD-1 inhibitor Keytruda (pembrolizumab) as a perioperative treatment for patients with resectable, locally advanced head and ...

President Trump said he thinks he could make amends with tech billionaire Elon Musk following their public feud, but doing so is not a priority for him. Trump was asked by the New York Post’s ...

The first patient has been dosed in the DESTINYEndometrial01 phase 3 trial evaluating Enhertu (trastuzumab deruxtecan) in combination with rilvegostomig or pembrolizumab versus platinum-based ...

Hanwha Systems, a leading Korean defense and aerospace technology company, announced Tuesday that it signed a memorandum of understanding (MOU) with BAE Systems, a premier British defense and ...

Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.